Discover how systemic inflammatory response markers enhance prognostic accuracy in hepatocellular carcinoma (HCC). This study presents important findings that improve current risk stratification models and support more precise clinical decision-making.

Read the full article: https://link.springer.com/article/10.1007/s12072-025-10806-6

#HCC#LiverCancer#InflammationMarkers#PrognosticModels#Hepatology#MedicalResearch#HepatologyInternational